Home/Filings/4/0001819790-23-000045
4//SEC Filing

CHAUDHURI BHASKAR 4

Accession 0001819790-23-000045

CIK 0001819790other

Filed

Jun 20, 8:00 PM ET

Accepted

Jun 21, 6:25 PM ET

Size

304.6 KB

Accession

0001819790-23-000045

Insider Transaction Report

Form 4
Period: 2023-06-16
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2023-06-162,0000 total
    Common Stock (2,000 underlying)
  • Exercise/Conversion

    Common Stock

    2023-06-16+2,0002,000 total
Footnotes (3)
  • [F1]The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.
  • [F2]Each RSU represents a contingent right to receive one share of the Company's common stock.
  • [F3]RSUs granted on June 16, 2022, in connection with the Reporting Person's service as a non-employee director as of the Company's 2022 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Issuer

Tarsus Pharmaceuticals, Inc.

CIK 0001819790

Entity typeother

Related Parties

1
  • filerCIK 0001458643

Filing Metadata

Form type
4
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 6:25 PM ET
Size
304.6 KB